Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Evagelia I. Habeos"'
Autor:
Panos Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana Kyriazopoulou, Ralitsa P Iskrenova, Evagelia I Habeos, Gerasimos P Sykiotis, Dionysios V Chartoumpekis, Ioannis G Habeos
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162024 (2016)
Fibroblast growth factor 21 (Fgf21) is a hormone with emerging beneficial roles in glucose and lipid homeostasis. The interest in Fgf21 as a potential antidiabetic drug and the factors that regulate its production and secretion is growing. Statins ar
Externí odkaz:
https://doaj.org/article/0002538f54ee4b8aa8030916319718a9
Autor:
Venetsana Kyriazopoulou, Dionysios V. Chartoumpekis, Panos G. Ziros, Gerasimos P. Sykiotis, Zoi Zagoriti, George Lagoumintzis, Ioannis Habeos, Evagelia I. Habeos, Ralitsa P. Iskrenova
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162024 (2016)
Plos One, vol. 11, no. 9, pp. e0162024
PLoS ONE
Plos One, vol. 11, no. 9, pp. e0162024
PLoS ONE
Fibroblast growth factor 21 (Fgf21) is a hormone with emerging beneficial roles in glucose and lipid homeostasis. The interest in Fgf21 as a potential antidiabetic drug and the factors that regulate its production and secretion is growing. Statins ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb8dde847d021082d141c7e034ef60e
http://europepmc.org/articles/PMC5008788?pdf=render
http://europepmc.org/articles/PMC5008788?pdf=render